Skip to main content
. 2023 Mar 22;616(7955):168–175. doi: 10.1038/s41586-023-05838-7

Extended Data Fig. 4. RHOJ mediates resistance to chemotherapy associated with EMT in human cancer cells.

Extended Data Fig. 4

a, qRT-PCR of Rhoj and Rhoq expression validating the specific downregulation of Rhoj after shRNA knockdown (Rhoj sh) in human breast cancer cell line MDA-MB-231 as compared to control cells. (n = 3 independent experiments, data are normalized using housekeeping gene Polr2a; Control shRNA (Control) is an empty shRNA vector). b, Relative cell number as compared to day 0 in MDA-MB-231 control and RhoJ shRNA knockdown cultured cells in vitro and quantified by performing crystal violet assay (Medians and range are shown, two-sided Mann-Whitney U-test, n represents triplicates from two biological replicates). c-d, Representative images (c) and cell survival analysis (d) after 48h of treatment with 8, 16, 24 μM cisplatin; 30, 100, 300 nM paclitaxel; 250, 500, 700 nM doxorubicin of MDA-MB-231 control cells and Rhoj shRNA knockdown (scale bar, 500 μm; box boundaries represent 25th and 75th percentiles; whiskers, minimum and maximum; centre line, median, two-sided Mann-Whitney U-test, n represents replicates from two biological replicates).